Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Oct;42(4):542–550. doi: 10.1038/bjc.1980.278

Antigenic modulation of mammary tumour virus envelope antigen or GR thymic lymphoma cells in relation to expressions of H-2, TL cell-surface antigens and THY1.

J Hilgers, A Sonnenberg, R Nusse
PMCID: PMC2010442  PMID: 6254554

Abstract

The MLr antigen, a mammary tumour virus-induced antigen on the surface of GR thymic lymphoma cells (GRSL) can be modulated from the cell surface upon incubation with specific antiserum for 1-2 h at 37 degrees C, followed by washing the cells. In contrast, a number of other cell-surface antigens on these GRSL cells cannot be modulated under similar conditions. These antigens include histocompatibility antigens of the H-2 complex (H-2.8 of the K-end and H-2dx(D) of the H-2dx haplotype) and two thymic markers, TL1.2 and Thy1.2. Antigenic modulation of MLr as tested by trypan-blue exclusion and by chromium51 release does not lead to a measurable change in the expression of H-2K, H-2D, TL and Thy1.2 antigens. These results could be confirmed by absorption analysis. The latter analysis showed that the number of antigenic sites per cell are about the same for MLr and the two H-2 antigens, while TL antigens are scarcer and Thy1.2 antigens are more abundant. The procedure of antigenic modulation showed that the MLr antigen resides on MTVgp52, the major protein of the envelope. There was no evidence of internal proteins, such as MTVp27, on the surface of GRSL cells.

Full text

PDF
542

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amiel J. L., Droz J. P. Staging and treatment of Hodgkin's disease. Eur J Cancer. 1978 Jan;14(1):1–4. doi: 10.1016/0014-2964(78)90131-7. [DOI] [PubMed] [Google Scholar]
  2. Aoki T., Johnson P. A. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation. J Natl Cancer Inst. 1972 Jul;49(1):183–192. [PubMed] [Google Scholar]
  3. Bubbers J. E., Lilly F. Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature. 1977 Mar 31;266(5601):458–459. doi: 10.1038/266458a0. [DOI] [PubMed] [Google Scholar]
  4. Calafat J., Buijs F., Hageman P. C., Links J., Hilgers J., Hekman A. Distribution of virus particles and mammary tumor virus antigens in mouse mammary tumors, transformed BALB-c mouse kidney cells, and GR ascites leukemia cells. J Natl Cancer Inst. 1974 Oct;53(4):977–992. doi: 10.1093/jnci/53.4.977. [DOI] [PubMed] [Google Scholar]
  5. Calafat J., Hilgers J., Van Bitterswijk W. J., Verbeet M., Hageman P. C. Antibody-induced modulation and shedding of mammary tumor virus antigens on the surfaces of GR ascites leukemia cells as compared with normal antigens. J Natl Cancer Inst. 1976 May;56(5):1019–1029. doi: 10.1093/jnci/56.5.1019. [DOI] [PubMed] [Google Scholar]
  6. Hilgers J., Haverman J., Nusse R., van Blitterswijk W. J., Cleton F. J., Hageman P. C., van Nie P., Calafat J. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells. J Natl Cancer Inst. 1975 Jun;54(6):1323–1333. doi: 10.1093/jnci/54.6.1323. [DOI] [PubMed] [Google Scholar]
  7. Hilgers J., Nowinski R. C., Geering G., Hardy W. Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res. 1972 Jan;32(1):98–106. [PubMed] [Google Scholar]
  8. Joachim H. L., Pearse A., Keller S. E. Antigenic deletion and malignant enhancement induced in lymphoma cells by passage through X-irradiated hosts. Nature. 1977 Jan 6;265(5589):55–57. doi: 10.1038/265055a0. [DOI] [PubMed] [Google Scholar]
  9. Joseph B. S., Oldstone M. B. Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation. J Exp Med. 1975 Oct 1;142(4):864–876. doi: 10.1084/jem.142.4.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mühlbock O., Dux A. Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice. J Natl Cancer Inst. 1974 Oct;53(4):993–996. [PubMed] [Google Scholar]
  11. Nordquist R. E., Anglin J. H., Lerner M. P. Antibody-induced antigen redistribution and shedding from human breast cancer cells. Science. 1977 Jul 22;197(4301):366–367. doi: 10.1126/science.877557. [DOI] [PubMed] [Google Scholar]
  12. Nusse R., Asselbergs F. A., Salden M. H., Michalides R. J., Bloemendal H. Translation of mouse mammary tumor virus RNA: precursor polypeptides are phosphorylated during processing. Virology. 1978 Nov;91(1):106–115. doi: 10.1016/0042-6822(78)90359-8. [DOI] [PubMed] [Google Scholar]
  13. Nusse R., van der Ploeg L., van Duijn L., Michalides R., Hilgers J. Impaired maturation of mouse mammary tumor virus precursor polypeptides in lymphoid leukemia cells, producing intracytoplasmic A particles and no extracellular B-type virions. J Virol. 1979 Oct;32(1):251–258. doi: 10.1128/jvi.32.1.251-258.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Old L. J., Stockert E., Boyse E. A., Kim J. H. Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med. 1968 Mar 1;127(3):523–539. doi: 10.1084/jem.127.3.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Old L. J., Stockert E. Immunogenetics of cell surface antigens of mouse leukemia. Annu Rev Genet. 1977;11:127–160. doi: 10.1146/annurev.ge.11.120177.001015. [DOI] [PubMed] [Google Scholar]
  16. REIF A. E., ALLEN J. M. THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES. J Exp Med. 1964 Sep 1;120:413–433. doi: 10.1084/jem.120.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. STUECK B., BOYSE E. A., OLD L. J., CARSWELL E. A. ML: A NEW ANTIGEN FOUND IN LEUKAEMIAS AND MAMMARY TUMOURS OF THE MOUSE. Nature. 1964 Sep 5;203:1033–1034. doi: 10.1038/2031033a0. [DOI] [PubMed] [Google Scholar]
  18. Sadeghee S., Hebert J., Kelley J., Abdou N. I. Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction. J Immunol. 1975 Sep;115(3):811–816. [PubMed] [Google Scholar]
  19. Schrader J. W., Cunningham B. A., Edelman G. M. Functional interactions of viral and histocompatibility antigens at tumor cell surfaces. Proc Natl Acad Sci U S A. 1975 Dec;72(12):5066–5070. doi: 10.1073/pnas.72.12.5066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Steeves R., Lilly F. Interactions between host and viral genomes in mouse leukemia. Annu Rev Genet. 1977;11:277–296. doi: 10.1146/annurev.ge.11.120177.001425. [DOI] [PubMed] [Google Scholar]
  21. Strzadala L., Steuden J., Radzikowski C. Molecular relationship between H-2 and ML antigens on leukaemia L-1210/v cells. J Immunogenet. 1977 Feb;4(1):29–33. doi: 10.1111/j.1744-313x.1977.tb00611.x. [DOI] [PubMed] [Google Scholar]
  22. Van Blitterswijk W. J., Emmelot P., Hilgers J., Kamlag D., Nusse R., Feltkamp C. A. Quantitation of virus-induced (MLr) and normal (Thy.1.2) cell surface antigens in isolated plasma membranes and the extracellular ascites fluid of mouse leukemia cells. Cancer Res. 1975 Oct;35(10):2743–2751. [PubMed] [Google Scholar]
  23. WIGZELL H. QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS. Transplantation. 1965 May;3:423–431. doi: 10.1097/00007890-196505000-00011. [DOI] [PubMed] [Google Scholar]
  24. van Blitterswijk W. J., Emmelot P., Hilkmann H. A., Hilgers J., Feltkamp C. A. Rigid plasma-membrane-derived vesicles, enriched in tumour-associated surface antigens (MLr), occurring in the ascites fluid of a murine leukaemia (GRSL). Int J Cancer. 1979 Jan 15;23(1):62–70. doi: 10.1002/ijc.2910230112. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES